ColoGuideEx receives attention
A prognostic test for colorectal cancer, developed by researchers at the Department of Cancer Prevention, receives attention from international researchers and from Norwegian media. The test, named ColoGuideEx, is a gene signature, where gene expression measurements from tumour tissue aid in prognostication of stage II colorectal cancer. The test was earlier this year published in the journal GUT.
Original scientific article:
Trude H. Ågesen, Anita Sveen, Marianne A. Merok, Guro E. Lind, Arild Nesbakken, Rolf I. Skotheim, and Ragnhild A. Lothe (2012). ColoGuideEx: a robust gene classifier specific for stage II colorectal cancer prognosis. Gut [Epub ahead of print]